CHA Vaccine Research Institute (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 3,170.00
-40.00 (-1.25%)
At close: Jul 18, 2025, 3:30 PM KST
KOSDAQ:261780 Revenue
CHA Vaccine Research Institute had revenue of -10.00 KRW in the twelve months ending March 31, 2025, down -100.00% year-over-year. In the year 2024, CHA Vaccine Research Institute had annual revenue of 370.66M with 26.02% growth.
Revenue (ttm)
-10.00
Revenue Growth
-100.00%
P/S Ratio
-8,516,282,982.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
85.16B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| KB Financial Group | 14.93T |
| Doosan Enerbility | 15.88T |